Results 291 to 300 of about 608,970 (315)

Drug development for CNS disorders: strategies for balancing risk and reducing attrition

Nature Reviews Drug Discovery, 2007
Menelas N Pangalos, Lee E Schechter, Orest Hurko   +2 more
exaly  

Has the role of WBRT in primary CNS lymphoma been settled?

Nature Reviews Clinical Oncology, 2011
Lisa M Deangelis, Deangelis Lisa M
exaly  

The conversion of -CN to -CNS in dogs.

Federation proceedings, 2010
R G, HORTON, R E, WESTON
openaire   +1 more source

Mir223 restrains autophagy and promotes CNS inflammation by targeting ATG16L1

Autophagy, 2019
Yinghui Ren, Lijuan Zhang, Yurong Da
exaly  

CNS

Clinical Nurse Specialist, 1994
openaire   +2 more sources

Matrix metalloproteinases and diseases of the CNS

Trends in Neurosciences, 1998
V Wee Yong, Peter A Forsyth, Dylan R Edwards   +2 more
exaly  

Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties

ACS Chemical Neuroscience, 2010
Travis T Wager, Patrick R Verhoest
exaly  

CN: CN: CWN Workshop

2024 20th International Conference on Wireless and Mobile Computing, Networking and Communications (WiMob)
openaire   +1 more source

CNS species and antimicrobial resistance in clinical and subclinical bovine mastitis

Veterinary Microbiology, 2011
Karin Persson Waller, A Aspan
exaly  

The development of CAR T cells for patients with CNS malignancies

Nature Reviews Clinical Oncology
Zev A Binder, Stephen J Bagley, Jessica B Foster   +2 more
exaly